Richard G. Himebrook

Richard G. Himebrook serves as a key procurement lead within W40M MRCO Europe, a U.S. Army agency under the Department of Defense responsible for sustaining combat-ready medical capabilities across European theaters. He manages the acquisition of high-precision medical diagnostic equipment, surgical instruments, and in-vitro diagnostic reagents critical to battlefield and garrison healthcare operations. His portfolio focuses on ensuring timely delivery of clinically validated devices and laboratory services that support rapid triage, point-of-care testing, and sustained clinical analytics for deployed forces. Himebrook’s acquisitions are mission-critical, requiring strict compliance with military medical standards and rapid turnaround timelines to maintain operational readiness. He maintains long-standing relationships with leading global medical suppliers, including Roche Diagnostics S.p.A., Meditrade Medical Trading GmbH, and Colser Società Cooperativa, partnering primarily with established manufacturers and distributors of advanced diagnostic systems and surgical tooling. These vendor relationships are characterized by technical collaboration, regulatory alignment, and performance-based contract management to ensure equipment reliability in austere environments. Himebrook prioritizes vendors with proven track records in military-grade medical supply chains and robust quality assurance protocols. Himebrook’s contracting activity reflects a 100% no set-aside approach, indicating a preference for open competition among qualified global suppliers rather than socioeconomic set-asides. This strategy prioritizes technical capability, supply chain resilience, and rapid scalability over socioeconomic classifications, aligning with the urgent and specialized nature of combat medicine procurement. His primary procurement focus lies in NAICS 339112 (Surgical and Medical Instrument Manufacturing), 325413 (In-Vitro Diagnostic Substance Manufacturing), and 621511 (Medical Laboratories), reflecting deep expertise in clinical analyzers, diagnostic reagents, and laboratory service contracts. He routinely acquires devices requiring FDA and CE marking, with an emphasis on automation, portability, and compatibility with military health information systems.